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Abstract: Alopecia areata (AA) refers to noncicatricial hair loss. It is defined as a secondary psychiatric disorder in the 
classification of psycho dermatological disorders. Its profound effect on a person’s physical appearance and the resulting 
emotional stress have led many researchers to investigate psychiatric aspects of AA in recent decades [1, 2]. This study 
presents a review of the literature and highlights psychiatric aspects of AA. The results showed that both pediatric and 
adult patients with AA have a high risk of depression and anxiety. Dermatologists should consider a psychiatric 
evaluation of female patients under 20 years with AA to detect potential depression and anxiety. As much as alexithymia 
also in association of AA and other psychiatric disorders, such as schizophrenia, obsessive-compulsive disorder (OCD), 
personality, manic, bipolar, attention deficit, phobic disorders, further investigations are needed. The evaluation of the 
psychological status of patients with AA is extremely important to aid the well-being of individuals suffering from this 
disease. 
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INTRODUCTION 
Alopecia areata (AA) commonly presents as round 
or oval patches of noncicatricial hair loss. Other 
presentations of AA may include the loss of all scalp 
hair, loss of all body hair, and loss of hair in a band-like 
pattern (ophiasis) along the temporal and occipital 
scalp [1, 2]. The prevalence of AA is approximately 
0.2%, and the lifetime incidence is about 2.1% [1, 2]. It 
can be diagnosed both in pediatric and adult patients. 
Although the etiology of AA is unclear, genetic factors, 
autoimmunity, and environmental factors are thought to 
play important roles in the disease [3-5]. In 
histopathological evaluations, lymphocytic infiltration of 
T cells around and within the hair bulb region of 
anagen follicles are found. According to the 
unpredictable course of the disease, treatment options 
vary from topical to systemic treatments [6]. 
Psychodermatology refers to any aspect of 
dermatology in which psychological factors play a 
significant role. In the classification of 
psychodermatological disorders, AA is defined as a 
secondary psychiatric disorder in which the patient 
develops psychological problems as a result of a skin 
disease that causes physical disfigurement [7]. Given 
the profound effect of AA on a person’s physical 
appearance and the resulting emotional stress, which 
is accepted as one of the environmental factors in the 
etiology of this disease, many researchers have  
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investigated psychiatric aspects of the disease in 
recent decades [6]. Numerous studies have 
investigated personality traits and the psychopathology 
of patients with AA, as well as the effects of 
psychopathology on the symptom severity of the 
disease. The lifetime prevalence of any psychiatric 
disorder has been estimated at approximately 74% 
among patients with AA [8]. This study presents a 
review of the literature on AA and highlights psychiatric 
aspects of the disease. 
Personality Traits  
Several studies have investigated whether 
psychiatric disorders or personality traits predict AA. 
Alfani et al. compared the personality traits of AA 
patients and healthy controls with the Minnesota 
Multiphasic Personality Inventory [9]. They revealed 
that AA patients appeared to experience more 
depressive, hysterical, and anxiety feelings. They also 
pointed out that patients with AA had more 
hypochondriac tendencies and were more in conflict 
with their social environment. However, Carrizosa et al. 
found no differences in the personality traits of patients 
with AA compared to those with other dermatological 
diseases [10]. Two studies used the Temperament and 
Character Inventory to investigate the personality traits 
AA patients [11, 12]. One of the studies found no 
difference between AA patients and healthy controls, 
but the other reported that patients with AA had low 
novelty seeking, reward dependence, and self-
transcendence scores compared to those of healthy 
controls.
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Depression and Anxiety 
Depression and anxiety are the most frequent 
comorbid psychiatric disorders associated with AA in 
the English literature. The estimated lifetime 
prevalence of major depression and anxiety was 
reported to be 39% in AA patients [8]. In a nationwide 
analysis and comparison of 5117 AA patients and 
healthy controls from Taiwan, Chu et al. reported that 
patients with AA had an increased risk of anxiety and 
depression [13]. They also reported that major 
depressive disorder was associated with AA in those 
younger than 20 years. Several other studies found 
similar results [14-17]. In a retrospective cross-
sectional study of the prevalence of comorbid 
conditions among 2115 patients with AA during an 11-
year period, Huang et al. reported that 25.5% of the 
patients had depression or anxiety [18]. In a recent 
study, Aghaei et al. assessed the frequency of 
psychological disorders in patients with AA in 
comparison with that in healthy controls [19]. They 
reported that depression and anxiety were significantly 
higher in the patients with AA. Further, they suggested 
that the social background of the patients, such as 
having a lower educational level, might have influenced 
these findings. Supporting previous results, they 
mentioned the correlation between localization of 
deformation in this case AA lesions, such as face 
involvement and higher rates of depression and anxiety 
[20, 21]. Despite the high prevalence of depression and 
anxiety among patients with AA, another study of the 
prevalence of “wishing to be dead” and having acute 
suicidal thoughts among individuals with cosmetically 
disfiguring dermatological disorders found that none of 
the patients with AA had suicidal ideation [22]. A recent 
study of children with AA showed a positive relationship 
with the presence of AA and depression scores [23]. In 
this report, conflicting with previous data, only the state 
of anxiety score had a significant association with AA in 
the adolescent group. The higher prevalence of 
psychiatric morbidity among women with 
dermatological disease is well known. However, there 
are conflicting data in the literature on the association 
of AA with depression and anxiety according to the sex 
of the individual [24-26]. Nevertheless, in several 
reports, researchers found a female predominance of 
depression and anxiety in patients with AA [25, 26]. 
Alexithymia 
The data on the association of AA and alexithymia 
are conflicting [27, 28]. Sayar et al. reported that 58% 
of male patients (n=31) were alexithymic according to 
the Toronto Alexithymia Scale (TAS) [29]. In a 
comparison of patients with AA and healthy controls, 
Cordan Yazici et al. reported that patients with AA had 
higher TAS scores [30]. On the other hand, in a similar 
study, Picardi et al. reported no difference [31]. Parallel 
to the findings of Picardi et al.’s study, in a recently 
published report, Sellami et al. showed no significant 
difference in alexithymia between patients with AA and 
healthy controls [24, 31].  
Other Psychiatric Diseases 
Schizophrenia and obsessive-compulsive disorder 
(OCD), in addition to personality, manic, bipolar, 
attention deficit, and phobic disorders, have been 
reported in several case reports in a limited number of 
patients. Considering the limitations of these, data for 
these disorders are more beyond the proof of 
association between AA and them. In one study, Chu 
et al. compared the prevalence of these disorders in 
patients with AA and healthy controls and reported no 
significant difference in the prevalence among those 
with AA [13]. Interestingly, Chu et al. found an 
association between AA and OCD among those who 
were younger than 20 years. A different study showed 
that children with AA had more difficulties in 
concentration than those without AA [23]. 
According to the current literature presented above, 
we can conclude that both pediatric and adult patients 
with AA have a high risk of depression and anxiety. 
The data also suggest that dermatologists should 
consider a psychiatric evaluation of female AA patients 
who are younger than 20 years to detect depression 
and anxiety. The data on the association of AA with 
alexithymia are conflicting. More studies are needed to 
elucidate the association of AA with alexithymia and 
other psychiatric disorders, such as schizophrenia and 
OCD, in addition to personality, manic, bipolar, 
attention deficit, and phobic disorders. Based on this 
review of the current literature, evaluations of the 
psychological status of patients with AA are extremely 
important to aid the well-being of individuals suffering 
from this disease.  
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